Optimizing Risk Communication for Lynch Syndrome: Results of a Randomized Controlled Trial of Visual Arrays for
Jordan N Keels1, Viktoriya Babicheva2, Isabella R McDonald1
1William F. Connell School of Nursing, Boston College, Chestnut Hill, MA 02467, USA.
Abstract:
Background/Objectives: We aimed to test two different visual arrays for helping individuals accurately interpret colorectal cancer risk in Lynch syndrome. We also sought to examine factors associated with intention to share genetic test results with blood relatives. Methods: Participants were recruited through Amazon Mechanical Turk (July-August 2025). Participants completed an online REDCap survey evaluating genetic literacy/numeracy and risk perception (Tripartite Model of Risk Perception). Participants were randomized to a risk visualization-either a standard icon array or a sequential icon array intended to decrease cognitive load. Subsequently, participants were randomized to a communication choice scenario-a nondirective (choice) frame or an "enhanced choice" with a behavioral nudge based on the Theory of Planned Behavior. Results: Participants' (n = 1041) estimation of colorectal cancer risk did not differ according to visualization type (icon array: 60.36 ± 15.86%, sequential array: 60.91 ± 15.73%, p = 0.58). Intention to share genetic testing outcomes with family members was not influenced by the behavioral nudge (p = 0.23). Neither risk estimation nor intent to communicate results to blood relatives were affected by individual perceived colorectal cancer risk, health literacy/numeracy, education, previous genetic testing, personal cancer history, or family cancer history (all p > 0.11 and p > 0.21, respectively). Conclusions: This study found that visual array type did not affect estimated cancer risk, and decision frame did not affect intention to share genetic testing results. Findings could inform the development of online approaches to expand decision support for hereditary cancer syndromes (Clinicaltrials.gov #NCT06994832).
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Survival Analysis
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Relative Risk
Pharmacogenomics: Identification of New Drug Targets

